Camber Capital Management

Camber Capital Management as of June 30, 2017

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 32 positions in its portfolio as reported in the June 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Gilead Sciences (GILD) 13.8 $283M 4.0M 70.78
Spdr S&p 500 Etf (SPY) 11.8 $242M 1.0M 241.80
Teva Pharmaceutical Industries (TEVA) 10.2 $208M 6.3M 33.22
Mylan Nv 8.0 $165M 4.2M 38.82
Nektar Therapeutics (NKTR) 5.1 $105M 5.4M 19.55
Allergan 4.2 $85M 350k 243.09
Genomic Health 3.9 $80M 2.5M 32.55
Brookdale Senior Living (BKD) 3.9 $79M 5.4M 14.71
Myriad Genetics (MYGN) 3.8 $78M 3.0M 25.84
Tenet Healthcare Corporation (THC) 3.8 $77M 4.0M 19.34
Select Medical Holdings Corporation (SEM) 3.8 $77M 5.0M 15.35
Bioverativ Inc Com equity 3.5 $71M 1.2M 60.17
Orthofix International Nv Com Stk 3.4 $70M 1.5M 46.48
Vertex Pharmaceuticals Incorporated (VRTX) 2.2 $45M 350k 128.87
Sarepta Therapeutics (SRPT) 2.1 $44M 1.3M 33.71
Endo International (ENDPQ) 1.9 $40M 3.6M 11.17
Endologix 1.8 $37M 7.5M 4.86
AMAG Pharmaceuticals 1.5 $31M 1.7M 18.40
BioScrip 1.4 $28M 10M 2.72
Biogen Idec (BIIB) 1.3 $27M 100k 271.36
Syneron Medical Ltd ord 1.2 $26M 2.3M 10.95
Alexion Pharmaceuticals 1.2 $24M 200k 121.67
Axovant Sciences 1.1 $23M 1.0M 23.19
Invitae (NVTA) 1.1 $23M 2.4M 9.56
Envision Healthcare 1.1 $22M 350k 62.67
Avexis 0.8 $17M 210k 82.16
Rite Aid Corporation 0.7 $15M 5.0M 2.95
Ptc Therapeutics I (PTCT) 0.5 $9.2M 500k 18.33
Atara Biotherapeutics (ATRA) 0.4 $7.5M 536k 14.00
Arena Pharmaceuticals 0.3 $7.2M 425k 16.87
Radius Health 0.2 $4.5M 100k 45.23
Biolase Technology 0.0 $0 7.2M 0.00